Table 4 Medication indicators met by DMP participation, cardiologist consultation and sex
DMP participation | Cardiologist consultation | ||||
|---|---|---|---|---|---|
Sex | No N (%) | Yes N (%) | NoN (%) | YesN (%) | |
Indicator 6 Patients with heart failure and prescribed beta blocker | F | 6,817 (72.1) | 7,073 (78.6) | 8,987 (71.4) | 4,903 (83.6) |
M | 5,547 (73.7) | 8,373 (80.3) | 7,004 (71.4) | 6,916 (84.8) | |
Indicator 7 Patients after acute myocardial infarct and prescribed beta blocker | F | 348 (85.3) | 354 (85.5) | 509 (83.0) | 193 (92.3) |
M | 454 (84.7) | 609 (88.6) | 704 (84.4) | 359 (92.3) | |
Indicator 8 eligible Patients with prescribed statins | F | 7,575 (27.4) | 7,808 (48.7) | 10,070 (30.3) | 5,313 (50.8) |
M | 7,475 (37.1) | 11,846 (64.5) | 10,894 (41.5) | 8,427 (68.7) | |
Indicator 9 eligible Patients with heart failure and/or high blood pressure and prescribed ACE-inhibitors or AT-II antagonists | F | 25,797 (75.6) | 18,856 (79.6) | 33,009 (75.3) | 11,644 (83.2) |
M | 20,928 (79.1) | 21,740 (82.2) | 26,957 (77.7) | 15,711 (86.3) | |